# OPTIMized Diagnosis and Treatment System Based on AI and Multimodal Imaging Fusion for PCI (OPTIMAI-PCI)

Study · id `cardio:ct-nct07855614` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07855614](<https://clinicaltrials.gov/study/NCT07855614>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07855614

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 554 participants.

## Technical summary

Registry record NCT07855614. Randomized; double masking; primary purpose treatment. Start 2026-09 (anticipated); primary completion 2027-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 554 participants (planned count; ClinicalTrials.gov record NCT07855614, source copy `cardio:ctgov-nct07855614-2026-10-02`, retrieved 2026-10-26)
- Planned start: 2026-09 (anticipated) (ClinicalTrials.gov record NCT07855614, source copy `cardio:ctgov-nct07855614-2026-10-02`, retrieved 2026-10-26)
- Primary completion: 2027-12 (anticipated) (ClinicalTrials.gov record NCT07855614, source copy `cardio:ctgov-nct07855614-2026-10-02`, retrieved 2026-10-26)
- Completion: 2028-12 (anticipated) (ClinicalTrials.gov record NCT07855614, source copy `cardio:ctgov-nct07855614-2026-10-02`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07855614, source copy `cardio:ctgov-nct07855614-2026-10-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07855614-2026-10-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: OPTIMized Diagnosis and Treatment System Based on AI and Multimodal Imaging Fusion for PCI (OPTIMAI-PCI)
- Acronym: OPTIMAI-PCI
- Condition: Coronary Artery Disease
- Intervention (Device): AI-Based Imaging Fusion Guidance System
- Intervention (Procedure): Standard IVUS-Guided PCI
- Lead sponsor: Zhejiang Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)

## Provenance

Content hash: f16564a5204a9f343f7fcfdd591872b0efaac92cdcb23156d434e56956211827
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
